C | CHEMISTRY; METALLURGY | |||
Note(s) [2009.01]
| ||||
CHEMISTRY | ||||
C12 | BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING | |||
Note(s) [5]
| ||||
C12N | MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, microorganisms or animal material A01N 63/00; medicinal preparations A61K; fertilisers C05F); PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q 1/00) [3] | |||
Note(s) [2006.01]
| ||||
C12N 1/00 | Microorganisms, e.g. protozoa; Compositions thereof (medicinal preparations containing material from protozoa, bacteria or viruses A61K 35/66, from algae A61K 36/02, from fungi A61K 36/06; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, A61K 39/00); Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor [2006.01] | |||
C12N 1/02 | • Separating microorganisms from their culture media [2006.01] | |||
C12N 1/04 | • | |||
C12N 1/06 | • Lysis of microorganisms [2006.01] | |||
C12N 1/08 | • Reducing the nucleic acid content [2006.01] | |||
C12N 1/10 | • Protozoa; Culture media therefor [2006.01] | |||
C12N 1/11 | • • | |||
C12N 1/12 | • Unicellular algae; Culture media therefor (as new plants A01H 13/00) [2006.01] | |||
C12N 1/13 | • • | |||
C12N 1/14 | • Fungi (culture of mushrooms A01G 18/00; as new plants A01H 15/00); Culture media therefor [2006.01] | |||
C12N 1/15 | • • | |||
C12N 1/16 | • • Yeasts; Culture media therefor [2006.01] | |||
C12N 1/18 | • • • Baker's yeast; Brewer's yeast [2006.01] | |||
C12N 1/19 | • • • | |||
C12N 1/20 | • Bacteria; Culture media therefor [2006.01] | |||
C12N 1/21 | • • | |||
C12N 1/22 | • Processes using, or culture media containing, cellulose or hydrolysates thereof [2006.01] | |||
C12N 1/24 | • Processes using, or culture media containing, waste sulfite liquor [2006.01] | |||
C12N 1/26 | • Processes using, or culture media containing, hydrocarbons (refining of hydrocarbon oils by using microorganisms C10G 32/00) [2006.01] | |||
C12N 1/28 | • • aliphatic [2006.01] | |||
C12N 1/30 | • • • having five or less carbon atoms [2006.01] | |||
C12N 1/32 | • Processes using, or culture media containing, lower alkanols, i.e. C1 to C6 [2006.01] | |||
C12N 1/34 | • Processes using foam culture [2006.01] | |||
C12N 1/36 | • Adaptation or attenuation of cells [2006.01] | |||
C12N 1/38 | • Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound (C12N 1/34 takes precedence) [2006.01] | |||
C12N 3/00 | Spore-forming or isolating processes [2006.01] | |||
C12N 5/00 | ||||
C12N 5/02 | • Propagation of single cells or cells in suspension; Maintenance thereof; Culture media therefor [2006.01] | |||
C12N 5/04 | • | |||
C12N 5/07 | • Animal cells or tissues [2010.01] | |||
• Note(s) [2010.01]
| ||||
C12N 5/071 | • • Vertebrate cells or tissues, e.g. human cells or tissues [2010.01] | |||
C12N 5/073 | • • • Embryonic cells or tissues; Foetal cells or tissues [2010.01] | |||
C12N 5/0735 | • • • • Embryonic stem cells; Embryonic germ cells [2010.01] | |||
C12N 5/074 | • • • Adult stem cells [2010.01] | |||
C12N 5/075 | • • • Oocytes; Oogonia [2010.01] | |||
C12N 5/076 | • • • Sperm cells; Spermatogonia [2010.01] | |||
C12N 5/077 | • • • Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells [2010.01] | |||
C12N 5/0775 | • • • • Mesenchymal stem cells; Adipose-tissue derived stem cells [2010.01] | |||
C12N 5/078 | • • • Cells from blood or from the immune system [2010.01] | |||
C12N 5/0781 | • • • • B cells; Progenitors thereof [2010.01] | |||
C12N 5/0783 | • • • • | |||
C12N 5/0784 | • • • • Dendritic cells; Progenitors thereof [2010.01] | |||
C12N 5/0786 | • • • • Monocytes; Macrophages [2010.01] | |||
C12N 5/0787 | • • • • Granulocytes, e.g. basophils, eosinophils, neutrophils or mast cells [2010.01] | |||
C12N 5/0789 | • • • • Stem cells; Multipotent progenitor cells [2010.01] | |||
C12N 5/079 | • • • Neural cells [2010.01] | |||
C12N 5/0793 | • • • • Neurons [2010.01] | |||
C12N 5/0797 | • • • • Stem cells; Progenitor cells [2010.01] | |||
C12N 5/09 | • Tumour cells [2010.01] | |||
C12N 5/095 | • • Stem cells; Progenitor cells [2010.01] | |||
C12N 5/10 | • | |||
C12N 5/12 | • • Fused cells, e.g. hybridomas [2006.01] | |||
C12N 5/14 | • • • | |||
C12N 5/16 | • • • Animal cells [2006.01] | |||
C12N 5/18 | • • • • Murine cells, e.g. mouse cells [2006.01] | |||
C12N 5/20 | • • • • • one of the fusion partners being a B lymphocyte [2006.01] | |||
C12N 5/22 | • • • Human cells [2006.01] | |||
C12N 5/24 | • • • • one of the fusion partners being a B lymphocyte [2006.01] | |||
C12N 5/26 | • • • Cells resulting from interspecies fusion [2006.01] | |||
C12N 5/28 | • • • • one of the fusion partners being a human cell [2006.01] | |||
C12N 7/00 | Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (medicinal preparations containing viruses A61K 35/76; preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K 39/00) [2006.01] | |||
C12N 7/01 | • Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material (vectors C12N 15/00) [2006.01] | |||
C12N 7/02 | • Recovery or purification [2006.01] | |||
C12N 7/04 | • Inactivation or attenuation; Producing viral sub-units [2006.01] | |||
C12N 7/06 | • • | |||
C12N 7/08 | • • by serial passage of virus [2006.01] | |||
C12N 9/00 | Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth A61K 8/66, A61Q 11/00; medicinal preparations containing enzymes or proenzymes A61K 38/43; enzyme containing detergent compositions C11D); Processes for preparing, activating, inhibiting, separating, or purifying enzymes [2006.01] | |||
Note(s) [5]
| ||||
C12N 9/02 | • Oxidoreductases (1.), e.g. luciferase [2006.01] | |||
C12N 9/04 | • • acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1) [2006.01] | |||
C12N 9/06 | • • acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) [2006.01] | |||
C12N 9/08 | • • acting on hydrogen peroxide as acceptor (1.11) [2006.01] | |||
C12N 9/10 | • | |||
C12N 9/12 | • • transferring phosphorus containing groups, e.g. kinases (2.7) [2006.01] | |||
C12N 9/14 | • Hydrolases (3.) [2006.01] | |||
C12N 9/16 | • • acting on ester bonds (3.1) [2006.01] | |||
C12N 9/18 | • • • Carboxylic ester hydrolases [2006.01] | |||
C12N 9/20 | • • • • Triglyceride splitting, e.g. by means of lipase [2006.01] | |||
C12N 9/22 | • • • Ribonucleases [2006.01] | |||
C12N 9/24 | • • acting on glycosyl compounds (3.2) [2006.01] | |||
C12N 9/26 | • • • acting on alpha-1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase [2006.01] | |||
C12N 9/28 | • • • • Alpha-amylase from microbial source, e.g. bacterial amylase [2006.01] | |||
C12N 9/30 | • • • • • Fungal source [2006.01] | |||
C12N 9/32 | • • • • | |||
C12N 9/34 | • • • • Glucoamylase [2006.01] | |||
C12N 9/36 | • • • acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetylamino 2-deoxy-D-glucose, e.g. lysozyme [2006.01] | |||
C12N 9/38 | • • • acting on beta-galactose-glycoside bonds, e.g. beta-galactosidase [2006.01] | |||
C12N 9/40 | • • • acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase [2006.01] | |||
C12N 9/42 | • • • acting on beta-1, 4-glucosidic bonds, e.g. cellulase [2006.01] | |||
C12N 9/44 | • • • acting on alpha-1, 6-glucosidic bonds, e.g. isoamylase, pullulanase [2006.01] | |||
C12N 9/46 | • • • • Dextranase [2006.01] | |||
C12N 9/48 | • • acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4) [2006.01] | |||
C12N 9/50 | • • • Proteinases [2006.01] | |||
C12N 9/52 | • • • • derived from bacteria [2006.01] | |||
C12N 9/54 | • • • • • bacteria being Bacillus [2006.01] | |||
C12N 9/56 | • • • • • • Bacillus subtilis or Bacillus licheniformis [2006.01] | |||
C12N 9/58 | • • • • derived from fungi [2006.01] | |||
C12N 9/60 | • • • • • from yeast [2006.01] | |||
C12N 9/62 | • • • • • from Aspergillus [2006.01] | |||
C12N 9/64 | • • • • derived from animal tissue, e.g. rennin [2006.01] | |||
C12N 9/66 | • • • Elastase [2006.01] | |||
C12N 9/68 | • • • Plasmin, i.e. fibrinolysin [2006.01] | |||
C12N 9/70 | • • • Streptokinase [2006.01] | |||
C12N 9/72 | • • • Urokinase [2006.01] | |||
C12N 9/74 | • • • Thrombin [2006.01] | |||
C12N 9/76 | • • • Trypsin; Chymotrypsin [2006.01] | |||
C12N 9/78 | • • acting on carbon to nitrogen bonds other than peptide bonds (3.5) [2006.01] | |||
C12N 9/80 | • • • acting on amide bonds in linear amides [2006.01] | |||
C12N 9/82 | • • • • Asparaginase [2006.01] | |||
C12N 9/84 | • • • • Penicillin amidase [2006.01] | |||
C12N 9/86 | • • • acting on amide bonds in cyclic amides, e.g. penicillinase [2006.01] | |||
C12N 9/88 | • Lyases (4.) [2006.01] | |||
C12N 9/90 | • Isomerases (5.) [2006.01] | |||
C12N 9/92 | • • Glucose isomerase [2006.01] | |||
C12N 9/94 | • Pancreatin [2006.01] | |||
C12N 9/96 | • | |||
C12N 9/98 | • | |||
C12N 9/99 | • | |||
C12N 11/00 | Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof [2006.01] | |||
C12N 11/02 | • | |||
C12N 11/04 | • • entrapped within the carrier, e.g. gel, hollow fibre [2006.01] | |||
C12N 11/06 | • • attached to the carrier via a bridging agent [2006.01] | |||
C12N 11/08 | • • the carrier being a synthetic polymer [2006.01] | |||
C12N 11/10 | • • the carrier being a carbohydrate [2006.01] | |||
C12N 11/12 | • • • Cellulose or derivatives thereof [2006.01] | |||
C12N 11/14 | • | |||
C12N 11/16 | • | |||
C12N 11/18 | • | |||
C12N 13/00 | Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves [2006.01] | |||
C12N 15/00 | Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms C12N 1/00, C12N 5/00, C12N 7/00; new plants A01H; plant reproduction by tissue culture techniques A01H 4/00; new animals A01K 67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K 48/00; peptides in general C07K) [2006.01] | |||
Note(s) [3]
| ||||
C12N 15/01 | • Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor [2006.01] | |||
C12N 15/02 | • Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion [2006.01] | |||
C12N 15/03 | • • Bacteria [2006.01] | |||
C12N 15/04 | • • Fungi [2006.01] | |||
C12N 15/05 | • • | |||
C12N 15/06 | • • Animal cells [2006.01] | |||
C12N 15/07 | • • Human cells [2006.01] | |||
C12N 15/08 | • • Cells resulting from interspecies fusion [2006.01] | |||
C12N 15/09 | • Recombinant DNA-technology [2006.01] | |||
C12N 15/10 | • • Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H 21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P 19/34) [2006.01] | |||
C12N 15/11 | • • DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology C07H 21/00) [2006.01] | |||
C12N 15/113 | • • • Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides [2010.01] | |||
C12N 15/115 | • • • Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith [2010.01] | |||
C12N 15/117 | • • • Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs [2010.01] | |||
C12N 15/12 | • • • Genes encoding animal proteins [2006.01] | |||
C12N 15/13 | • • • • Immunoglobulins [2006.01] | |||
C12N 15/14 | • • • • Human serum albumins [2006.01] | |||
C12N 15/15 | • • • • Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin [2006.01] | |||
C12N 15/16 | • • • • Hormones [2006.01] | |||
C12N 15/17 | • • • • • Insulins [2006.01] | |||
C12N 15/18 | • • • • • Growth hormones [2006.01] | |||
C12N 15/19 | • • • • Interferons; Lymphokines; Cytokines [2006.01] | |||
C12N 15/20 | • • • • • Interferons [2006.01] | |||
C12N 15/21 | • • • • • • Alpha-interferons [2006.01] | |||
C12N 15/22 | • • • • • • Beta-interferons [2006.01] | |||
C12N 15/23 | • • • • • • Gamma-interferons [2006.01] | |||
C12N 15/24 | • • • • • Interleukins [2006.01] | |||
C12N 15/25 | • • • • • • Interleukin-1 [2006.01] | |||
C12N 15/26 | • • • • • • Interleukin-2 [2006.01] | |||
C12N 15/27 | • • • • • Colony stimulating factors [2006.01] | |||
C12N 15/28 | • • • • • Tumor necrosis factors [2006.01] | |||
C12N 15/29 | • • • | |||
C12N 15/30 | • • • Genes encoding protozoal proteins, e.g. from Plasmodium, Trypanosoma, Eimeria [2006.01] | |||
C12N 15/31 | • • • Genes encoding microbial proteins, e.g. enterotoxins [2006.01] | |||
C12N 15/32 | • • • • Bacillus crystal proteins [2006.01] | |||
C12N 15/33 | • • • • Genes encoding viral proteins [2006.01] | |||
C12N 15/34 | • • • • • Proteins from DNA viruses [2006.01] | |||
C12N 15/35 | • • • • • • Parvoviridae, e.g. feline panleukopenia virus, human parvovirus [2006.01] | |||
C12N 15/36 | • • • • • • Hepadnaviridae [2006.01] | |||
C12N 15/37 | • • • • • • Papovaviridae, e.g. papillomaviruses, polyomavirus, SV40 [2006.01] | |||
C12N 15/38 | • • • • • • Herpetoviridae, e.g. herpes simplex virus, varicella-zoster virus, Epstein-Barr virus, cytomegalovirus, pseudorabies virus [2006.01] | |||
C12N 15/39 | • • • • • • Poxviridae, e.g. vaccinia virus, variola virus [2006.01] | |||
C12N 15/40 | • • • • • Proteins from RNA viruses, e.g. flaviviruses [2006.01] | |||
C12N 15/41 | • • • • • • Picornaviridae, e.g. rhinovirus, coxsackie viruses, echoviruses, enteroviruses [2006.01] | |||
C12N 15/42 | • • • • • • • Foot-and-mouth disease virus [2006.01] | |||
C12N 15/43 | • • • • • • • Poliovirus [2006.01] | |||
C12N 15/44 | • • • • • • Orthomyxoviridae, e.g. influenza virus [2006.01] | |||
C12N 15/45 | • • • • • • Paramyxoviridae, e.g. measles virus, mumps virus, Newcastle disease virus, canine distemper virus, rinderpest virus, respiratory syncytial viruses [2006.01] | |||
C12N 15/46 | • • • • • • Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus [2006.01] | |||
C12N 15/47 | • • • • • • Rhabdoviridae, e.g. rabies viruses, vesicular stomatitis virus [2006.01] | |||
C12N 15/48 | • • • • • • Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus [2006.01] | |||
C12N 15/49 | • • • • • • • Lentiviridae, e.g. immunodeficiency viruses such as HIV, visna-maedi virus, equine infectious anaemia virus [2006.01] | |||
C12N 15/50 | • • • • • • Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus [2006.01] | |||
C12N 15/51 | • • • • • Hepatitis viruses [2006.01] | |||
C12N 15/52 | • • • | |||
• • • Note(s) [5]
| ||||
C12N 15/53 | • • • • Oxidoreductases (1) [2006.01] | |||
C12N 15/54 | • • • • Transferases (2) [2006.01] | |||
C12N 15/55 | • • • • Hydrolases (3) [2006.01] | |||
C12N 15/56 | • • • • • acting on glycosyl compounds (3.2), e.g. amylase, galactosidase, lysozyme [2006.01] | |||
C12N 15/57 | • • • • • acting on peptide bonds (3.4) [2006.01] | |||
C12N 15/58 | • • • • • • Plasminogen activators, e.g. urokinase, TPA [2006.01] | |||
C12N 15/59 | • • • • • • Chymosin [2006.01] | |||
C12N 15/60 | • • • • Lyases (4) [2006.01] | |||
C12N 15/61 | • • • • Isomerases (5) [2006.01] | |||
C12N 15/62 | • • • DNA sequences coding for fusion proteins [2006.01] | |||
• • • Note(s) [5]
| ||||
C12N 15/63 | • • | |||
C12N 15/64 | • • • | |||
C12N 15/65 | • • • using markers (enzymes used as markers C12N 15/52) [2006.01] | |||
C12N 15/66 | • • • | |||
• • • Note(s) [5]
| ||||
C12N 15/67 | • • • General methods for enhancing the expression [2006.01] | |||
C12N 15/68 | • • • • | |||
C12N 15/69 | • • • • | |||
C12N 15/70 | • • • | |||
• • • Note(s) [5]
| ||||
C12N 15/71 | • • • • Expression systems using regulatory sequences derived from the trp-operon [2006.01] | |||
C12N 15/72 | • • • • Expression systems using regulatory sequences derived from the lac-operon [2006.01] | |||
C12N 15/73 | • • • • Expression systems using phage lambda regulatory sequences [2006.01] | |||
C12N 15/74 | • • • | |||
• • • Note(s) [5]
| ||||
C12N 15/75 | • • • • for Bacillus [2006.01] | |||
C12N 15/76 | • • • • for Actinomyces; for Streptomyces [2006.01] | |||
C12N 15/77 | • • • • for Corynebacterium; for Brevibacterium [2006.01] | |||
C12N 15/78 | • • • • for Pseudomonas [2006.01] | |||
C12N 15/79 | • • • | |||
• • • Note(s) [5]
| ||||
C12N 15/80 | • • • • for fungi [2006.01] | |||
C12N 15/81 | • • • • • for yeasts [2006.01] | |||
C12N 15/82 | • • • • | |||
C12N 15/83 | • • • • • | |||
C12N 15/84 | • • • • • Ti-plasmids [2006.01] | |||
C12N 15/85 | • • • • for animal cells [2006.01] | |||
C12N 15/86 | • • • • • | |||
C12N 15/861 | • • • • • • | |||
C12N 15/863 | • • • • • • | |||
C12N 15/864 | • • • • • • | |||
C12N 15/866 | • • • • • • | |||
C12N 15/867 | • • • • • • | |||
C12N 15/869 | • • • • • • | |||
C12N 15/87 | • • | |||
C12N 15/873 | • • • Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos [2010.01] | |||
C12N 15/877 | • • • • Techniques for producing new mammalian cloned embryos [2010.01] | |||
C12N 15/88 | • • • using microencapsulation, e.g. using liposome vesicle [2006.01] | |||
C12N 15/89 | • • • using microinjection [2006.01] | |||
C12N 15/90 | • • • Stable introduction of foreign DNA into chromosome [2006.01] |